Oleic, Lauric, Palmitic, Myristic, and Stearic Acids are fatty acids with hydrocarbon chains ranging in length from 12 to 18 carbons with a terminal carboxyl group. These fatty acids are absorbed, digested, and transported in animals and humans. Little acute toxicity was observed when Ofeic, Lauric, Palmitic, Myristic, or Stearic Acid or cosmetic formulations containing these fatty acids were given to rats orally at doses of 15-19 g/kg body weight. Feeding of 15% dietary Oleic Acid to rats in a chronic study resulted in normal growth and health, but reproductive capacity of female rats was impaired. Results from topical application of Oleic, Palmitic, and Stearic Acid to the skin of mice, rabbits, and guinea pigs produced little or no apparent toxicity. Studies using product formulations containing Oleic and Stearic acids indicate that neither is a sensitizer or photosensitizing agent. Animal studies also indicate that these fatty acids are not eye irritants. Lauric, Stearic, and Oleic Acids were noncarcinogenic in separate animal tests. In primary and cumulative irritation clinical studies, Oleic, Myristic, and Stearic Acids at high concentrations were nonirritating. Cosmetic product formulations containing Oleic, Lauric, Palmitic, and Stearic Acids at concentrations ranging up to 13% were not primary or cumulative irritants, nor sensitizers. On the basis of available data from studies using animals and humans, it is concluded that Oleic, Lauric, Palmitic, Myristic, and Stearic Acids are safe in present practices of use and concentration in cosmetics.
References
1.
Windholz, M., Budavari, S., Blumetti, R.F., and Otterbein, E.S. (eds.). (1983). The Merck Index, 10th ed.Rahway, NJ: Merck and Co.
Swern, D. (ed.). (1979). Bailey's industrial Oil and Fat Products, 4th ed.New York: John Wiley & Sons, Vol. 1.
7.
Weast, R.C. (ed.). (1982). CRC Handbook of Chemistry and Physics, 63rd ed.Boca Raton, FL: CRC Press.
8.
FOOD CHEMICALS CODEX (FCC), 3rd ed. (1981). Washington, DC: National Academy Press.
9.
Balsam, M.S. and Sagarin, E. (1972). Cosmetics: Science and Technology, 2nd ed.New York: John Wiley & Sons, Vols. 1, 2, 3.
10.
Marzulli, F.N. and Maibach, H.I. (1977). Contact allergy: predictive testing in humans, in Advances in Modern Toxicology. Dermatology and Pharmacology, New York: John Wiley & Sons, Vol. 4, Chap. 11, pp. 353–72.
11.
Fassett, D.W. and Irish, D.D. (eds.). (1963). industrial Hygiene and Toxicology, 2nd ed. Toxicology. New York: Interscience Publishers, Vol. 2.
12.
UNITED STATES PHARMACOPEIA (USP), 20th rev. (July 1, 1980). Rockville, MD: US. Pharmacopeial Convention.
13.
Cosmetic, TOILETRY AND FRAGRANCE ASSOCIATION (CTFA). (Feb. 22, 1979). CTFA cosmetic ingredient chemical description. Lauric Acid.*
Wilkinson, J.B. and Moore, R.J. (1982). Harry's Cosmeticology, 7th ed.New York: Chemical Publishing, p. 724.
19.
Elder, R.L. (ed.). (1980). Final report of the safety assessment of acetylated lanolin alcohol and related compounds. J. Environ. Pathol. Toxicol. 4(4), 69.
20.
Hawley, G.G. (ed.). (1977). Condensed Chemical Dictionary, 9th ed.New York: Van Nostrand Reinhold Co.
21.
Estrin, N.F., Haynes, C.R., and Whelan, J.M. (1982). CTFA Compendium of Cosmetic Ingredient Composition. Specifications/Spectra. Washington, DC: CTFA.
22.
CTFA. (Feb. 1979). Submission of unpublished data. (3-3-93). Clinical skin irritation and sensitization study on 8 percent stearic acid in shave foam.*
23.
NATIONAL FORMULARY (NF), 15th ed. (July 1, 1980). Rockville, MD: U.S. Pharmacopeial Convention.
24.
Motoyoshi, K. (1983). Enhanced comedo formation in rabbit ear skin by squalene and oleic acid peroxides. Br. J. Dermatol.109(2), 191–8.
25.
Horwitz, W. (ed.). (1980). Official Methods of Analysis of the Association of Official Analytical Chemists (AOAC), 13 ed.Washington, DC: AOAC.
Allen, K.G., MacGee, J., Fellows, M.E., Tornheim, P.A., and Wagner, K.R. (1984). A new procedure to analyze free fatty acids. Application to 20-mg brain tissue samples. J. Chromatogr.309(1), 33–42.
28.
Gerhardt, K.O. and Gehrke, C.W. (1977). Rapid microdetermination of fatty acids in biological materials by gas-liquid chromatography. J. Chromatogr.143(4), 335–44.
29.
Penttila, I., Huhtikangas, A., Herranen, J., Eskelinen, S., and Moilanen, O. (1984). Simultaneous measurement of free and esterified fatty acids by gas chromatography from normal and type IV hyperlipoproteinaemic sera. Ann. Clin. Res.16(1), 13–7.
30.
Takatori, T., Terazawa, K., Nakano, K., and Matsumiya, H. (1983). Identification of 10-hydroxy-12-octadecenoic acid in adipocere. Forensic Sci. Int.23(2-3), 117–22.
31.
VAN DE Vaart, F.J., Hulshoff, A., and Inoemans, A.W.M. (1983). Analysis of creams. V. Application of thin-layer chromatography. Parts I and II. Pharmaceutisch Weekblad Sci. Ed.5(3), 109–18.
32.
Smith, R.M. (1983). Recent advances in the high-performance liquid chromatography of fatty acids. J. Pharm. Biomed. Anal.1(2). 143–51.
33.
Lie Ken Jie, M.S.F. (1980). The characterization of long-chain fatty acids and their derivatives by chromatography, in Giddings, J.C., Grushka, E., Cazes. J., and Brown, P.R. (eds.). Advances in Chromatography. New York: Marcel Dekker, Vol. 18, Chap. 1.
34.
Davis, D.V. and Cooks, R.G. (1982). Direct characterization of nutmeg constituents by mass spectrometry-mass spectrometry. J. Agric. Food Chem.30(3), 495–504.
35.
Shimasaki, H. and Ueta, N. (1983). Fractionation of the neutral lipids of rice-bran oil by centrifugal liquid chromatography. Agric. Biol. Chem.47(2), 327–9.
36.
Cyong, J. and Okada, H. (1976). Histochemical studies on fatty acid in lymphocyte-mediated immune reaction. Immunology30(5), 763–7.
37.
Arudi, R.L., Sutherland, M.W., and Bielski, B.H.J. (1983). Purification of oleic acid and linoleic acid. J. Lipid Res.24(4), 485–8.
38.
Bailey, A.V. and Pittman, R.A. (1971). Wide-line NMR spectra of some saturated and unsaturated long chain fatty acids. J. Am. Oil Chem. Soc.48(12), 775–7.
39.
Eiermann, H.J. Acting Director, Division of Colors and Cosmetics, Food and Drug Administration. (June 12, 1986). Letter to R.L. Elder, Cosmetic Ingredient Review, on Oleic Acid Croup, Methylene Chloride, and Clyceryl Ricinoleate.*
40.
Creenberg, L.A. and Lester, D. (1954). Handbook of Cosmetic Materials: Their Properties, Uses and Toxic and Dermatologic Actions. New York: Interscience Publishers.
41.
FOOD AND DRUG ADMINISTRATION (FDA). (1981). Cosmetic product formulation data. FDA computer printout.
42.
CODE OF FEDERAL REGULATIONS. (1984). Title 21. Food and Drugs. Parts 172.5[a], 172.210, 172.315, 172.340, 172.615, 172.840, 172.860, 172.862, 172.863, 174.5, 175.105, 175.300, 176.200. 182.70. 182.90, 184.1090, 720.4. Washington, DC: U.S. Government Printing Office.
FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY (FASEB). (1977). Evaluation of the health aspects of coconut oil, peanut oil, and oleic acid as they may migrate to food from packaging materials, and linoleic acid as a food ingredient. SCOGS-65. NTIS Doc. no. PB-274-475.
45.
FASEB. (1975). Evaluation of the health aspects of tallow, hydrogenated tallow, stearic acid and calcium stearate as food ingredients. SCOGS-54. NTIS Doc. no. PB-262-661.
46.
Informatics, INC. (July 1973). Scientific literature reviews on generally recognized as safe (GRAS) food ingredients, tallow and stearic acid. Prepared for FDA under contract no FDA-72-104. NTIS No. PB-223 859.
47.
Informatics, INC. (1973). Monograph on vegetable oils, oleic acid, and linoleic acid. Vol, 1. NTIS Doc. no. PB-228 546/8.
FDA. (Dec. 8, 1977). Unpublished industry submission. Two-generation reproduction study in the rat. FDA file FAP 3428, Vol. 1, pp. 52-83.
50.
FDA. (Nov. 3, 1969). Unpublished industry submission. Hercules Inc. 90-day subacute oral toxicity of commercial food grade oleic acid (Emersol 6333) in albino rats. FDA file FAP 2504, Vol. 1, pp. 161-72.
51.
FDA. (1953). Unpublished industry submission, Pilot feeding studies of rats with sodium lactate (41 percent) + stearic acid (59 percent) or calcium lactate (41 percent) + stearic acid (59 percent). FDA file FAP 215, Vol. 1, pp. 163-299.
52.
FDA, (March 13, 1959). Unpublished industry submission. One month feeding studies of vervic acid in rats. Comparison with calcium very and stearic acid. FDA file FAP 215, Vol. 3, pp. 630-70.
53.
FDA. (April 29, 1957). Unpublished industry submission. The chronic toxicity of octadecylamine. Final Report. FDA file FAP 22, Vol. 1, pp. 19-32.
54.
AMERICAL MEDICAL ASSOCIATION (AMA). (April 1983). AMA Drug Evaluations. Chicago, IL: AMA.
55.
FDA. (January 1984). The Division of OTC Drug Evaluation Ingredient Status Report. Rockville, MD.
56.
Checchi, A.A., INC. (August 1979; December, 1979; March 1982; October 1983). Recommended or final actions of OTC advisory review panels on miscellaneous external drug products, topical analgesic, antirheumatic, otic, burn, sunburn treatment and prevention products, antimicrobial Ii, and contraceptive and other vaginal drug products, respectively. OTC Drug Ingredient Index and Manual.
57.
Brown, J.L. (1983). Incomplete labeling of pharmaceuticals: A list of “inactive” ingredients. N. Engl. J. Med.309(7), 439–41.
58.
Shen, D.-F., Huang, A., and Huang, L. (1982). An improved method for covalent attachment of antibody to liposomes. Biochim. Biophys. Acta689(1), 31–7.
59.
MIGLIORE-Samour, D., FLOC'H, F., Maral, R., Werner, G.H., and Jolles, P. (1977). Adjuvant activities of chemically modified water-soluble substances from Mycobacterium tuberculosis. Immunology33(4), 477–84.
60.
Siegfried, J.A., Kennedy, K.A., Sartorelli, A.C., and Tritton, T.R. (1983). The role of membranes in the mechanism of action of the antineoplastic agent adriamycin. Spin-labeling studies with chronically hypoxic and drug-resistant tumor cells. J. Biol. Chem.258(1), 339–43.
61.
Fowler, J.S. and Wolf, A.P. (1981). Special characteristics and potential for radiotracers for positron emission tomography. Acupunct. Electrother. Res.6(2-3), 81–108.
62.
Elder, R. (ed.). (1982). Final report on the safety assessment of decyl and isodecyl oleates. J. Am. Coil. Toxicol. 1(2), 85-95.
63.
COSMETIC INGREDIENT REVIEW (CIR). (1985). Tentative report on the safety assessment of Clyceryl Oleate.*
64.
Borgstrom, B. (1974). Fat digestion and absorption. Biomembranes48(0), 555–620.
65.
Brindley, D.N. (1974). The intracellular phase of fat absorption. Biomembranes48(0), 621–71.
66.
Scow, R.O., Blanchette-Mackie, E.J., and Smith, L.C. (July 1980). Transport of lipid across capillary endothelium. Fed. Proc.39(9), 2610–7.
67.
Westera, G., Van Der Wall, E.E., Visser, F.C., Den Hollander, W., Heidendal, G.A.K., and Roos, J.P. (1983). The uptake of iodinated free fatty acids in the (ischemic) dog heart. Indications for a dual uptake mechanism. Int. J. Nucl. Med. Biol.10(4), 231–6.
68.
FASEB. (1977). Evaluation of the health aspects of sodium oleate and sodium palmitate as substances migrating to food from paper and paper-board used in food packaging. SCOGS-86. NTIS Doc. no. PB-276-414.
69.
Opdyke, O.L. (ed.). (1979). Monographs on fragrance raw materials. Stearic Acid. Food Cosmet. Toxicol. 17(4), 383-8.
70.
NUTRITION REVIEWS. (1969). Glyceride structure and fat absorption. Biochem. J.27, 18. In Opdyke, 1979, Ref. 69.
71.
Andrews, R.J. and Lewis, D. (1970). Utilization of dietary fats by ruminants. II. Effect of fatty acid chain length and unsaturation on digestibility. J. Agric. Sci. Camb.75, 55. In Opdyke, 1979, Ref. 69.
72.
Butcher, E.O. (1951). The effects of application of various substances in the epidermis of the rat. J. Invest. Dermatol.16, 88.
73.
Butcher, E.O. (1953). The penetration of fats and fatty acid into the skin of the rat. J. Invest. Dermatol.21, 44.
74.
Scheuplein, R.J. (1965). Mechanism of percutaneous absorption. I. Routes of penetration and influence of solubility. J. Invest. Dermatol.45, 334.
75.
Beierwaltes, W.H., Ice, R.D., Shaw, M.J., and Ryo, U.Y. (1975). Myocardial uptake of labeled oleic and linoleic acids. J. Nucl. Med.16(9), 842–5.
76.
Goldberg, M. and Escaig, F. (1984). An autoradiographic study of the in vivo incorporation of [3H]-palmitic acid into the dentine and enamel lipids of rat incisors, with a comparison of rapid-freezing freeze-substitution fixation and aldehyde fixation. Arch. Oral Biol.29(9), 691–5.
77.
Dhopeshwarkar, G.A. and Mead, J.F. (1973). Uptake and transport of fatty acids into the brain and the role of the blood-brain barrier system. Adv. Lipid. Res.11, 109–42.
78.
Abumrad, N.A., Park, J.H., and Park, C.R. (1984). Permeation of long-chain fatty acid into adipocytes. Kinetics, specificity, and evidence for involvement of a membrane protein. J. Biol. Chem.259(14), 8945–53.
79.
Harris, P., Gloster, J.A., and Ward, B.J. (1980). Transport of fatty acids in the heart. Arch. Mal. Coeur73(6), 593–8.
Gibson, G.G., Orton, T.C., and Tamburini, P.P. (1982). Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12-and 11-hydroxylation of dodecanoic acid (lauric acid). Biochem. 1.203(1), 161–8.
Wakil. S.J. and Barnes, E.M. (1971). Pyruvate and fatty acid metabolism, in Florkin, M., and Stotz, E.H. (eds.). Comprehensive Biochemistry. New York: Elsevier Publ. Co., Vol. 185.
84.
Gellhorn, A. and Benjamin, W. (1966). Fatty acid biosynthesis and RNA function in fasting, aging and diabetes. Adv. Enzyme Regul.4, 19–41.
85.
Oscai, L.B. (1981). Exercise and lipid metabolism, in Nutrition in the 1980's: Constraints on Our Knowledge. Western Hemisphere Nutrition Congress, 1980. New York: A.R. Liss, pp. 383–90.
Kimura, R.E. and Warshaw, J.B. (1983). Metabolic adaptations of the fetus and newborn. J. Pediatr. Castroenterol. Nutr.2(1), 512–515,
89.
Goodwin, T.W. (ed.). (1977). lnternational Review of Biochemistry. Biochemistry of Lipids. Baltimore, MD: University Park Press, Vol. 14, Part 2.
90.
Reitz, R.C. (1979). The effects of ethanol ingestion on lipid metabolism. Prog. Lipid Res.18(2), 87–115.
91.
Baraona, E. and Lieber, C.S. (1979). Effects of ethanol on lipid metabolism. J. Lipid Res.20(3), 289–315.
92.
Lech, I.J., Jesmok, G.J., and Calvert, D.N. (1977). Effects of drugs and hormones on lipolysis in heart. Fed. Proc.36(7), 2000–8.
93.
Zammitt, V.A. (1983). Regulation of hepatic fatty acid oxidation and ketogenesis. Proc. Nutr. Soc.42, 289–302.
94.
Zakim, D. and Herman, R.H. (1969). Regulation of fatty acid synthesis. Am. J. Clin. Nutr.22(2), 200–13.
95.
Numa, S. (1974). Regulation of fatty-acid synthesis in higher animals. Ergeb. Physiol.69, 54–96.
96.
Wakil, S.J., Stoops, J.K., and Joshi, V.C. (1983). Fatty acid synthesis and its regulation. Annu. Rev. Biochem.52, 537–79.
97.
Pedersen, N.T. (1984). Estimation of assimilation of simultaneously ingested 14C-triolein and 3H-oleic acid as a test of pancreatic digestive function. Scand. J. Castroenterol.19(2), 161–6.
98.
Schelbert, H.R., Henze, E., Schon, H.R., Keen, R., Hansen, H., Selin, C., Huang, S.-C., Barrio, J.R., and Phelps, M.E. (1983). C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism. Am. Heart J.105(3), 492–503.
99.
Sauer, F.D. and Kramer, J.K.G. (1980). The metabolism of long-chain monoenoic fatty acids in heart muscle and their cardiopathogenic implications. Adv. Nutr. Res.24, 207–30.
100.
Whereat, A.F. (1971). Fatty acid biosynthesis in aorta and heart. Adv. Lipid Res.9, 119–59.
101.
Kummerow, F.A. (1983). Modification of cell membrane composition by dietary lipids and its implications for atherosclerosis. Ann. NY Acad. Sci.414, 29–43.
102.
Pearce, J. (1983). Fatty acid synthesis in liver and adipose tissue. Proc. Nutr. Soc.42(2), 263–71.
103.
Jeffcoat, R. (1979). The biosynthesis of unsaturated fatty acids and its control in mammalian liver. Essays Biochem.15,1–36.
104.
Mayes, P.A. (1970). Studies on the major pathways of hepatic lipid metabolism using the perfused liver. Horm. Metab. Res.2,186–95.
105.
Gangl, A. and Ockner, R.K. (1975). Intestinal metabolism of lipids and lipoproteins. Castroenterology68(1), 167–86.
106.
Eyssen, H. (1973). Role of the gut microflora in metabolism of lipids and sterols. Proc. Nutr. Soc.32(2), 59–63.
107.
Miras, F., Hernandez, J., DE LA HIGUERA Torres-P, J., Nunez, I., Martin, A., and DE LA HIGUERA R., J. (1983). Studies on the fate of labelled almitic acid in rat lung. Comp. Biochem. Physiol.75C(1), 179–84.
108.
Wirthensohn, G. and Guder, W.G. (1983). Renal lipid metabolism. Min. Electrolyte Metab.9, 203–11.
109.
Stoff, J.S., Epstein, F.H., Narins, R., and Relman, A.S. (1976). Recent advances in renal tubular biochemistry. Annu. Rev. Physiol.38, 46–68.
110.
Hohenegger, M. (1975). Lipid metabolism of the kidney: Possible relations to sodium transport. Curr. Probl. Clin. Biochem.4, 150–6.
111.
Zuurveld, J.G. and Veerkamp, J.H. (1984). Palmitate oxidation in suspended skeletal muscle fibers from the rat. Biochim. Biophys. Acta796(1), 34–41.
112.
Dunham, J., Dodds, R.A., Nahir, A.M., Frost, G.T.B., Catterall, A., Bitensky, L., and Chayen, J. (1983). Aerobic glycolysis of bone and cartilage: The possible involvement of fatty acid oxidation. Cell Biochem. Funct.1(3), 168–72.
113.
Harris, R.R. and Mackenzie, I.C. (1984). Fatty-acid metabolism in oral mucosal epithelium of the hamster. J. Oral Pathol.13(4), 394–400.
114.
Elphick, M.C., Hudson, D.G., and Hull, D. (1975). Transfer of fatty acids across the rabbit placenta. J. Physiol.252, 29–42.
115.
Hershfield, M.S. and Nemeth, A.M. (1968). Placental transport of free palmitic and linoleic acids in the guinea-pig. J. lipid Res.9, 460–468.
116.
Hummel, L., Schirrmeister, W., and WAGNER., H. (1975). Quantitative evaluation of the maternal fetal transfer of free fatty acids in the rat. Biol. Neonate26, 263–7.
117.
Elphick, M.C., Filshie, G.M., and Hull, D. (1978). The passage of fat emulsion across the human placenta. Br. J. Obstet. Cynecol.85, 610–8.
118.
Booth, C., Elphick, M.C., Hendrickse, W., and Hull, D. (1981). Investigation of 14C-linoleic acid conversion into 14C-arachidonic acid and placental transfer of linoleic and palmitic acids across the perfused human placenta. J. Dev. Physiol.3(3), 177–89.
119.
Thomas, C.R. and Lowy, C. (1982). The clearance and placental transfer of free fatty acids and triglycerides in the pregnant guinea-pig. J. Dev. Physiol.4, 163–73.
120.
Hummel, L., Schinckmann, R., and Zimmermann, T. (1983). Maternal-fetal transfer of free fatty acids during late gestation in the rat. Biomed. Biochim. Acta42(1), 143–5.
121.
AMERICAN MEDICAL ASSOCIATION (AMA). (1972). Diet and coronary heart disease: A joint policy statement of the American Medical Association Council on Foods and Nutrition and the Food and Nutrition Board of the National Academy of Sciences-National Research Council. IAMA 222, 1647. In Faseb, Refs.44, 45.
122.
COSMETIC INGREDIENT REVIEW (CIR). (Feb. 21, 1985). Final report on the safety assessment of Cholesterol.*
123.
Reiser, R. (1973). Saturated fat in the diet and serum cholesterol concentration: A critical examination of the literature. Am. J. Clin. Nutr.26, 524–55. In Faseb, Ref. 45.
124.
Oliver, M.F. (1982). Diet and coronary heart disease, in Human Nutrition: Clinical Nutrition. London: John Libbey, Vol. 36C(6), pp. 413–27.
125.
Kabara, J.J. (1978). Structure function relationships of surfactants as antimicrobial agents. J. Soc. Cosmet. Chem.29, 733–41.
126.
Kabara, J.J. (1984). Antimicrobial agents derived from fatty acids. J. Am. Oil Chem. Soc.61(2), 397–403.
127.
Priyadarshini, E. and Tulpule, P.G. (1980). Effect of free fatty acids on aflatoxin production in a synthetic medium. Food Cosmet. Toxicol.18(4), 367–9.
128.
Kohn, A., Citelman, J., and Inbar, M. (1980). Unsaturated free fatty acids inactivate animal enveloped viruses. Arch. Virol.66(4), 301–7.
129.
CTFA. (Sept. 26, 1978). Submission of unpublished data. (3-3-29). Acute oral toxicity data summary sheet on Oleic Acid.*
130.
INTERNATIONAL BIO-RESEARCH-US., INC. (Jan. 23, 1974). Submission of unpublished data by CTFA. (3-3-2, 3-3-92). Acute toxicity and irritation studies on a series of fatty acids: high purity Stearic Acid, triple pressed Stearic Acid, Lauric Acid, Oleic Acid, Myristic Acid and Palmitic Acid.*
131.
CTFA. (July 20, 1981). Submission of unpublished data. (3-3-96). Acute oral toxicity study using rats, dermal toxicity and ocular irritation studies using rabbits: 5 percent Oleic Acid in cream.*
132.
CTFA. (Sept. 11, 1973). Submission of unpublished data. (3-3-22). Acute oral toxicity data summary sheet on Lauric Acid.*
133.
CTFA. (Aug. 23, 1983). Submission of unpublished data. (3-3-89). Animal oral toxicity, dermal toxicity, skin irritation and ocular irritation studies: data summary sheet on Palmitic Acid in shave cream.*
134.
WARF INSTITUTE. (Jan. 13, 1978). Submission of unpublished data by CTFA. (3-3-1). Acute oral toxicity, primary skin irritation, and primary eye irritation of Stearic Acid.*
135.
CTFA. (Jan. 23, 1969). Submission of unpublished data. (3-3-85). Oral toxicity study data summary sheet on Stearic Acid in face cream.*
136.
CONSUMER PRODUCT TESTING CO., INC. (CPT). (Aug. 7, 1982). Submission of unpublished data by CTFA. (3-3-110). Primary dermal irritation in rabbits, primary ocular irritation in rabbits, and acute oral toxicity in rats of 2.8 percent Stearic Acid in skin lotion.*
137.
CPT. (Aug. 7, 1982). Submission of unpublished data by CTFA. (3-3-115). Primary dermal irritation in rabbits, primary ocular irritation in rabbits, and acute oral toxicity in rats of 2.8 percent Stearic Acid in skin lotion.*
138.
CPT. (Oct. 10, 1978). Submission of unpublished data by CTFA. (3-3-124; 3-3-125). Primary dermal irritation in rabbits, ocular irritation in rabbits, and acute oral toxicity in rats of 2.8 percent Stearic Acid in skin lotion.*
139.
CPT. (Sept. 23, 1980). Submission of unpublished data by CTFA. (3-3-116). Primary dermal irritation in rabbits, primary ocular irritation in rabbits, and acute oral toxicity in rats of 2.8 percent Stearic Acid in hand lotion.*
140.
TOX MONITOR Laboratories, INC. (TML). (Aug. 28, 1981). Submission of unpublished data by CTFA. (3-3-123). Eye irritation, primary skin irritation and acute oral toxicity testing of 2.8 percent Stearic Acid in lotion.*
141.
TML. (March 24, 1983). Submission of unpublished data by CTFA. (3-3-118). Eye irritation and acute oral toxicity testing of 2.8 percent Stearic Acid in lotion.*
142.
TML. (March 24, 1983). Submission of unpublished data by CTFA. (3-3-120). Eye irritation and acute oral toxicity testing of 2.8 percent Stearic Acid in lotion.*
143.
TML. (April 5. 1983). Submission of unpublished data by CTFA. (3-3-121). Eye irritation and acute oral toxicity testing of 2.8 percent Stearic Acid in lotion.*
144.
Price, G.E. and Beutner, R.H. (1960). Stearic acid as a poison. Fed. Proc.19(1 Pt. 1), 388. In: Informatics, Ref. 46.
145.
Sunde, M.L. (1956). The effects of fats and fatty acids in chick rations. Poultry Sci.35(2), 362–8. In: Informatics, Refs. 46, 47; Faseb, Ref. 68; Opdyke, Ref. 69.
146.
Beilharz, R.B. and McDonald, M.W. (1959). The use of high quality fat and the effect of protein level in broiler diets. Poultry Sci.38, 519–26. In: Informatics, Ref. 46.
147.
Renaud, S. (1968). Thrombogenicity and atherogenicity of dietary fatty acids in rat. J. Atheroscler. Res.8, 625. In: Opdyke, Ref. 69; Informatics, Refs. 46, 47.
148.
Renaud, S. (1969). Thrombotic, atherosclerotic and lipemic effects of dietary fats in the rat. Angiology20, 657. In: Opdyke, Ref. 69; Informatics, Refs. 46, 47.
149.
Herting, D.C. and Crain, R.C. (1958). Foreign-body type reaction in fat cells. Proc. Soc. Exp. Biol. Med.98(2), 347–8. In: Informatics, Ref. 46.
150.
Carroll, K.K. and Noble, R.L. (1957). Influence of a dietary supplement of erucic acid and other fatty acids on fertility in the rat. Sterility caused by erucic acid. Can. J. Biochem. Physiol.35(11), 1093–106. In: Informatics, Ref. 47.
151.
Herting, D.C., Harris, P.L., and Crain, R.C. (1959). Lipogranuloma from dietary saturated fats: Production and reversal. Toxicol. Appl. Pharmacol.1, 505–14. In: Faseb, Ref. 68.
152.
Deichmann, W.B., Radomski, J.L., MacDonald, W.E., Kascht, R.L., and Erdmann, R.L. (1958). The chronic toxicity of octadecylamine. Arch. Industr. Health.18, 483–7. In: Informatics, Ref. 46; Opdyke, Ref. 69.
153.
CTFA. (Sept. 18, 1978). Submission of unpublished data. (3-3-30). Acute dermal toxicity data summary sheet on Oleic Acid.*
154.
Flesch, P. (1953). Hair loss from sebum. Arch. Dermatol. Syph.67, 1–9. In: Informatics, Ref. 47.
155.
Puhvel, S.M. and Ertl, D.C. (1984). Decreased induction of aryl hydrocarbon hydroxylase activity in hyperproliferative hairless mouse epidermis. Br. J. Dermatol.110(1), 29–35.
156.
Berlin, B.S. and Wyman, R. (1971). Fractionation of Arlacel Al. Proc. Soc. Exp. Biol. Med.136, 1363–8. In: Informatics, Ref. 47.
157.
Stillman, M.A., Maibach, H.I., and Shalita, A.R. (1975). Relative irritancy of free fatty acids of different chain length. Contact Dermatitis1, 65. In: Opdyke, Ref. 69.
158.
CODE OF FEDERAL REGULATIONS. (1982). Title 16. Commercial Practices Parts 1500.3, 1500.40, 1500.41, 1500.42: Testing Methods. Washington, DC: Government Printing Office.
159.
Kanaar, P. (1971). Follicular-keratogenic properties of fatty acids in the external ear canal of the rabbit. Dermatologica142, 14–22.
160.
Setala, K., Merenmies, L., Stjernvall, L., Aho, Y., and Kajanne, P. (1959). Mechanism of experimental tumorigenesis. I. Epidermal hyperplasia in mouse caused by locally applied tumor initiator and Dipole-type tumor promoter. J. Natl. Cancer Inst.23, 925–51. In: Informatics, Ref. 47.
161.
Rantuccio, F., Sinisi, D., Scardigno, A., and Coviello, C. (1981). Histological changes in rabbits after application of medicaments and cosmetic bases (II). Contact Derm.7(2), 94–7.
162.
CTFA. (Aug. 14, 1974). Submission of unpublished data. (3-3-10). Safety evaluation of 2.0 percent Stearic Acid in 01 B/62568-J(6020). Four-week subacute dermal toxicity study in rabbits.*
163.
CTFA. (Aug. 14, 1974). Submission of unpublished data. (3-3-16). Four-week subacute dermal toxicity study in rabbits: 2.0 percent Stearic Acid.*
164.
CTFA. (July 11. 1980). Submission of unpublished data. (3-3-21). Study project 0135. The safety evaluation of two sun protection products and one facial skin care product. Thirteen-week subchronic dermal toxicity study in albino female rats on 5.0 percent Stearic Acid.*
165.
CTFA, (Aug. 18, 1982). Submission of unpublished data. (3-3-15). Study project 0191. The safety evaluation of three make-up products: 2.4 percent Stearic Acid in 03G/18218-12. Thirteen-week subchronic dermal toxicity study using female albino rats.*
166.
Robertson, T.B., Dawbarn, M.C., Thomas, R.G., Walters, J.W., and Wilson, J.D.O. (1933). Experiments on the growth and longevity of the white mouse. I. The influence of injections of thorium oleate in oleic acid, and of oleic acid alone, on growth and longevity. Aust. J. Exp. Biol. Med. Sci.11, 99–108. In: Faseb, Ref. 68.
167.
CTFA. (April 24, 1972). Submission of unpublished data. (3-3-32). Primary skin irritation data summary sheet on Oleic Acid.*
168.
Draize, J.H. (1959). In Appraisal of the Safety of Chemicals in Foods, Drugs and Cosmetics. Austin, TX: Association of Food and Drug Officials of the United States.
169.
CTFA. (Sept. 30, 1982). Submission of unpublished data. (3-3-51). Dermal irritation assessment data summary sheet on Oleic Acid in cream blusher.*
170.
CTFA. (March 17, 1983). Submission of unpublished data. (3-3-50). Dermal irritation assessment data summary sheet on Oleic Acid in cream blush.*
171.
CTFA. (May 14, 1973). Submission of unpublished data. (3-3-24). Primary skin irritation data summary sheet on Lauric Acid.*
172.
BIO-TOXICOLOGY LABORATORIES. (April 19, 1973). Submission of unpublished data by CTFA. Primary irritation studies on 45 percent Stearic Acid plus other fatty acids and on 74 percent Palmitic Acid plus other fatty acids in two product formulations.*
173.
CTFA. (June 4, 1979). Submission of unpublished data. (3-3-37). Primary skin irritation data summary sheet on Palmitic Acid.*
174.
CTFA. (June 4, 1979). Submission of unpublished data. (3-3-39). Primary skin irritation data summary sheet on Palmitic Acid.*
175.
CTFA. (April 24, 1972). Submission of unpublished data. (3-3-26). Primary skin irritation data summary sheet on Myristic Acid.*
176.
CTFA. (Feb. 27, 1978). Submission of unpublished data. (3-3-3). Primary skin irritation data summary sheet on Stearic Acid.*
177.
CTFA. (Nov. 15, 1976). Submission of unpublished data. (3-3-5). Primary skin irritation data summary sheet on Stearic Acid.*
178.
CTFA. (Jan. 10, 1977). Submission of unpublished data. (3-3-7). Primary skin irritation data summary sheet on Stearic Acid.*
179.
CTFA. (Jan. 21, 1983). Submission of unpublished data. (3-3-86). Skin and ocular irritation study: Data summary sheet on Stearic Acid in face cream.*
180.
CTFA. (Feb. 3, 1978). Submission of unpublished data. (3-3-82). Skin irritation testing with albino rabbits: Data summary sheet on Stearic Acid in lotion.*
181.
CTFA. (Nov. 12, 1982). Submission of unpublished data. (3-3-49). Guinea pig maximization test data summary sheet on Oleic Acid in cream blush.*
182.
Magnusson, B. and Kligman, A.M. (1969). The identification of contact allergens by animal assay. The guinea pig maximization test. J. Invest. Dermatol.52(3), 268–76.
183.
CTFA. (Feb. 3, 1978). Submission of unpublished data. (3-3-55). Guinea pig maximization study data summary sheet on Stearic Acid in suntan lotion.*
184.
CTFA. (July 8, 1981). Submission of unpublished data. (3-3-17). Project number GPA-07-81. Guinea pig allergy study protocol for the Magnusson-Kligman procedure on four raw ingredients and one finished product: 3.5 percent Stearic Acid.*
185.
CPT. (Jan. 5, 1983). Submission of unpublished data by CTFA. (3-3-113). Phototoxicity and photoallergy testing in guinea pigs of 2.8 percent Stearic Acid in skin lotion.*
186.
CPT. (Jan. 5, 1983). Submission of unpublished data by CTFA. (3-3-111). Phototoxicity and photoallergy testing in guinea pigs of 2.8 percent Stearic Acid in skin lotion.*
187.
CTFA. (April 24, 1972). Submission of unpublished data. (3-3-4). Eye irritation data summary sheet on Oleic Acid.*
188.
CTFA. (Sept. 18, 1972). Submission of unpublished data. (3-3-31). Eye irritation data summary sheet on Oleic Acid.*
189.
HAZELTON Laboratories, INC. (Dec. 11, 1974). Submission of unpublished data by CTFA. (3-3-66). Eye irritation study in monkeys on mascara EMM-4-120 and mascara EMM-4-122 each containing 6 percent Oleic Acid.*
190.
LEBERCO LABORATORIES. (June 14, 1984). Submission of unpublished data by CTFA. (3-3-107). Eye irritation study in rabbits of mascara containing 3 percent Oleic Acid.*
191.
LEBERCO LABORATORIES. (June 22, 1982). Submission of unpublished data by CTFA. (3-3-101). Eye irritation study in rabbits of mascara containing 2 percent Oleic Acid.*
192.
LEBERCO LABORATORIES. (Oct. 22, 1984). Submmion of unpublished data by CTFA. (3-3-105). Eye irritation study in rabbits of mascara containing 2 percent Oleic Acid.*
193.
CTFA. (May 15, 1973). Submission of unpublished data. (3-3-23). Eye irritation data summary sheet on Lauric Acid.*
194.
194 Stillmeadow, INC. (April 1, 1980). Submission of unpublished data by CTFA. (3-3-62). Rabbit eye irritation study on soap containing 1.95 percent Lauric Acid.*
195.
CTFA. (Feb. 6, 1985). Submission of unpublished data. (3-3-36). Eye irritation data summary sheet on Palmitic Acid.*
196.
CTFA. (Feb. 20, 1985). Submission of unpublished data. (3-3-35). Eye irritation data summary sheet on Palmitic Acid.*
197.
CTFA. (June 11, 1979). Submission of unpublished data. (3-3-38). Eye irritation data summary sheet on Palmitic Acid.*
198.
CTFA. (June 25, 1979). Submission of unpublished data. (3-3-40). Eye irritation data summary sheet on Palmitic Acid.*
199.
CTFA. (April 24, 1972). Submission of unpublished data. (3-3-25). Eye irritation data summary sheet on Myristic Acid.*
200.
Stillmeadow, INC. (March 30, 1982). Submission of unpublished data by CTFA. (3-3-60). Rabbit eye irritation study on lotion containing 1.5 percent Myristic Acid.*
201.
Stillmeadow, INC. (March 30, 1982). Submission of unpublished data by CTFA. (3-3-61). Rabbit eye irritation study on lotion containing 1.5 percent Myristic Acid.*
202.
CTFA. (Nov. 15, 1976). Submission of unpublished data. (3-3-6). Eye irritation data summary sheet on Stearic Acid.*
203.
CTFA. (Jan. 10, 1977). Submission of unpublished data. (3-3-8). Eye irritation data summary sheet on Stearic Acid.*
204.
CTFA. (March 29, 1977). Submission of unpublished data. (3-3-84). Eye irritation testing with albino rabbits: Data summary sheet on Stearic Acid in lotion.*
205.
Parry, J.M., Parry, E.M., and Barrett, J.C. (1981). Tumor promoters induce mitotic aneuploidy in yeast. Nature (London)294, 263–5.
206.
Ames, B.N., McCann, J., and Yamasaki, E. (1975). Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res.31, 347–64.
207.
Blevins, R.D. and Taylor, D.E. (1982). Mutagenicity screening of twenty-five cosmetic ingredients with the Salmonella/microsome test. J. Environ. Sci. HealthA17(2), 217–39.
208.
Kinsella, A.R. (1982). Elimination of metabolic cooperation and the induction of sister chromatid exchanges are not properties common to all promoting or co-carcinogenic agents. Carcinogenesis (London)3(5), 499–503.
209.
Graff, G. and Lands, W.E.M. (1982). Selective mutational loss of mitochrondrial function can be caused by certain unsaturated fatty acids Fed. Proc.41, 626.
210.
Hayatsu, H., Arimoto, S., Togawa, K., and Makita, M. (1981). Inhibitory effect of the ether extract of human feces on activities of mutagens: inhibition by oleic and linoleic acids. Mutat. Res.81(3), 287–93.
211.
Negishi, T., Ohara, Y., and Hayatsu, H. (1982). A sensitive assay for mutagenic activity of N-nitrosamines and its use for detection of modulators of the mutagenicity. IARC Sci. Publ. Iss. N-Nitroso Compd. Occurrence Biol. Eff. Vol. 41, pp. 685–94.
212.
Negishi, T. and Hayatsu, H. (1984). Inhibitory effect of saturated fatty acids on the mutagenicity of N-nitrosodimethylamine. Mutat. Res.135(2), 87–96.
213.
Pagano, D.A. and Zeiger, E. (1983). Suppressive effects of chemicals in mixture on the Salmonella plate test response in the absence of apparent toxicity. Environ. Mutagen.5, 473–4.
214.
Hayatsu, H. (1982). Modulation of mutagenesis by biological substances. Environ. Mutagens Carcinog. Proc. 3rd Int. Conf., 1981, pp. 521–6.
215.
Swern, D., Wieder, R., McDonouch, M., Meranze, D.R., and Shimkin, M.B. (1970). Investigation of fatty acids and derivatives for carcinogenic activity. Cancer Res.30(4). 1037–46.
216.
Szepsenwol, J. and Boschetti, N.V. (1975). Primary and secondary heart tumors in mice maintained on various diets. Oncology32(2), 58–72.
217.
Szepsenwol, J. (1978). Castro-intestinal tumors in mice of three strains maintained on fat-enriched diets. Oncology35(4), 143–52.
218.
El-Khatib, S.M. and Cora, E.M. (1981). Role of high-fat diet in tumorigenesis in C57BL/1 mice. J. Natl. Cancer Inst.66(2), 297–301.
219.
Twort, C.C. and Fulton, J.D. (1930). Further experiments on the carcinogenicity of synthetic tars and their fractions. J. Pathol. Bacteriol.33(1), 119–44. In: Informatics, Ref. 16.
220.
Hieger, I. (1959). Carcinogenesis by cholesterol, Br. J. Cancer13, 439–51. In: Informatics, Ref. 45.
221.
Van Duuren, B.L., Katz, C., Shimkin, M.B., Swern, D., and Wieder, R. (1972). Replication of low-level carcinogenic activity bioassays. Cancer Res.32(4), 880–1.
222.
Tinsley, I.J., Schmitz, J.A., and Pierce, D.A. (1981). Influence of dietary fatty acids on the incidence of mammary tumors in the C3H mouse. Cancer Res.41(4), 1460–5.
223.
Twort, J.M. and Twort, C.C. (1939). Comparative activity of some carcinogenic hydrocarbons. Am. J. Cancer35, 80–5.
224.
Shubik, P (1950) Studies on the promoting phase in the stages of carcinogenesis in mice, rats, rabbits and guinea pigs. Cancer Res.10, 13–7.
225.
Gwynn, R.H. and Salaman, M.H. (1953). Studies on cocarcinogenesis. SH-Reactors and other substances tested for cocarcinogenic action in mouse skin. Br. J. Cancer7, 482–9.
226.
Holsti, P. (1959). Tumor-promoting effects of some long chain fatty acids in experimental skin carcinogenesis in the mouse. Acta. Pathol. Microbiol. Scand.46, 51–8.
227.
Van Duuren, B.L. and Goldschmidt, B.M. (1976). Cocarcinogenic and tumor-promoting agents in tobacco carcinogenesis. J. Natl. Cancer Inst.56(6), 1237–42.
228.
Hogan, M.L. and Shamsuddin, A.M. (1984). Large intestinal carcinogenesis. I. Promotional effect of dietary fatty acid isomers in the rat model. J. Natl. Canc. Inst.73(6), 1293–6.
229.
Carroll, K.K. (1981). Neutral fats and cancer. Cancer Res41, 3695–9.
230.
Prunieras, M. (1979). Carcinogenicity of cosmetic materials, in Cohen, Y. (ed.). Adv. Pharmacol. Ther., Proc. 7th Int. Congr. Pharmacol, 1978. Oxford, England: Pergamon, Vol. 9, pp. 277–87.
231.
Morisaki, N., Sprecher, H., Milo, G.E., and Cornwell, D.G. (1982). Fatty acid specificity in the inhibition of cell proliferation and its relationship to lipid peroxidation and prostaglandin biosynthesis. Lipids17(12), 893–9.
232.
Booyens, J., Engelbrecht, P., Le Roux, S., Louwrens, C.C., Van Der Merwe, C.F., and Katzeff, J.E. (1984). Some effects of the essential fatty acids linoleic acid and alpha-linoleic acid and of their metabolites gamma-linoleic acid, arachidonic acid, eicosapentaenoic acid, docosahexaenoic acid, and of prostaglandins A1 and E1 on the proliferation of human osteogenic sarcoma cells in culture. Prostaglandins Leukotrienes Med.15(1), 15–33.
233.
Barka, T. and Van Der Noen, H. (1982). Culture of A-431 human epidermoid carcinoma cells in serum-free medium: effect of culture conditions on the binding of 125I-epidermal growth factor. Am. J. Anat.165(2), 187–98.
234.
Huttner, J.J., Milo, G.E., Panganamala, R.V., and Cornwell, D.G. (1978). Fatty acids and the selective alteration of in vitro proliferation in human fibroblast and guinea-pig smooth-muscle cells. In Vitro14(10), 854–9.
235.
Traul, K.A., Hink. R.J., Jr., Kachevsky, V., and Wolff, J.S., III. (1981). Two-stage carcinogenesis in vitro: Transformation of 3-methylcholanthrene-initiated Rauscher murine leukemia virus-infected rat embryo cells by diverse tumor promoters. J. Natl. Cancer Inst.66(1), 171–6.
236.
Welsch, C.W. and Aylsworth, C.F. (1983). Enhancement of murine mammary tumorigenesis by feeding high levels of dietary fat: A hormonal mechanism?J. Natl. Cancer Inst.70(2), 215–21.
237.
Diamond, L., O'Brien, T.G., and Baird, W.M. (1980). Tumor promoters and the mechanism of tumor promotion. Adv. Canc. Res.32, 1–74.
238.
Ando, K., Kato, A., Kimura, T., Suzuki, S., Tamura, G., and Arima, K. (1970). Antitumor activity of fatty acids and their esters. I. Evaluation of antitumor activity of fatty acids. Prog. Antimicrob. Anticancer Chemother.2, 136–41.
239.
Bottenstein, J.E. (1980). Serum-free culture of neuroblastoma cells. Prog. Cancer Res. Ther.12, 161–70.
240.
Ito, H., Kasama, K., Naruse, S., and Shimura, K. (1982). Antitumor effect of palmitoleic acid on Ehrlich ascites tumor. Cancer Lett.17(2), 197–203.
241.
Nelson, R.L. and Samelson, S.L. (1984). Inability of the mutagen-blocking agent oleic acid to protect against colon carcinogenesis in the rat. Mutat. Res.140(2-3), 155–7.
242.
Hummel, L., Schirrmeister, W., Zimmerman, T., and Wagner, H. (1974). Studies of the lipid metabolism using carbon-14-1-palmitate in fetal rats. Biol. Neonate24(5-6), 298–305.
243.
NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH (NIOSH). (June 1981). Health hazard evaluation report on lauric acid exposure during flaking and bagging operations at Emery Industries, Los Angeles, CA. HHE 80-160-897. NTIS Doc. no. PB82-25694 2.
244.
CTFA. (April 5, 1972). Submission of unpublished data. (3-3-33). Skin irritation potential (human patch test) data summary sheet on Oleic Acid.*
245.
CTFA. (Oct. 5, 1972). Submission of unpublished data. (3-3-34). Skin irritation potential (human patch test) data summary sheet on Oleic Acid.*
246.
CTFA. (January 1984). Submission of unpublished data. (3-3-78). Clinical skin irritation study data summary sheet on Oleic Acid in mineral oil.*
247.
CTFA. (January 1985). Submission of unpublished data. (3-3-75). Clinical skin irritation study data summary sheet on Oleic Acid in bar soap.*
248.
CTFA. (January 1984). Submission of unpublished data. (3-3-76). Clinical skin irritation study data summary sheet on Oleic Acid in bar soap.*
249.
CTFA. (March 1985). Submission of unpublished data. (3-3-74). Clinical skin irritation study data summary sheet on 2.53 to 40 percent Oleic Acid in bar soap.*
250.
HILL TOP Research, INC. (HTR). (Dec. 9, 1974). Submission of unpublished data by CTFA. (3-3-67). Lanman tests of cumulative irritant properties on a series of test materials. A clinical study on black cream mascara EMM-4-120 and brown cream mascara EMM-4-122 containing 6 percent Oleic Acid.*
251.
Frosch, P.J. and Kligman, A.M. (1979). The soap chamber test. J. Am. Acad. Dermatol.1, 35–41.
252.
Lanman, E.M., Elvers, W.B., and Howard, C.S. (1968). The role of human patch testing in a product development program. Proceedings Joint Conference Cosmet. Sci. Washington, DC: The Toilet Goods Association, Inc., pp. 35–45.
253.
Phillips, L., Steinberg, M., Maibach, H.I., and Akers, W.A. (1972). A comparison of rabbit and human skin response to certain irritants. J. Toxicol. Appl. Pharmacol.21, 369–82.
254.
Haynes, C.R. and Estrin, N.F. (eds.). (1983). CTFA safety testing guidelines. Guidelines for controlled use studies. CTFA Technical Guidelines. Washington, DC: Ctfa, Chap. 10.
255.
HTR. (Aug. 17, 1982). Submission of unpublished data by CTFA. (3-3-97). Report of a human skin test of cumulative irritation on a red paste formulation containing 5 percent Oleic Acid.*
256.
Maibach, H.I. (July 21, 1982). Submission of unpublished data by CTFA. (3-3-99 3-3-102). Study No. 82-A-1-2. 21-Day cumulative irritancy assay of mascara containing 2 percent Oleic Acid.*
257.
CTFA. (Oct. 7, 1983). Submission of unpublished data. (3-3-90). Clinical skin irritation, sensitization, and photosensitization studies: Data summary sheet on Palmitic Acid in shave cream.*
258.
CTFA. (March 22, 1983). Submission of unpublished data. (3-3-91). Clinical facial skin irritation study: Data summary sheet on Palmitic Acid in shave cream.*
259.
CTFA. (April 26, 1972). Submission of unpublished data. (3-3-27). Skin irritation potential (human patch test) data summary sheet on Myristic Acid.*
260.
CTFA. (January 1984). Submission of unpublished data. (3-3-70). Clinical skin iritation study data summary sheet on Myristic Acid.*
261.
CTFA. (January 1984). Submission of unpublished data. (3-3-72). Clinical skin irritation study data summary sheet on Myristic Acid in bar soap.*
262.
CTFA. (January 1985). Submission of unpublished data. (3-3-71). Clinical skin irritation study data summary sheet on Myristic Acid in bar soap.*
263.
CTFA. (March 1985). Submission of unpublished data. (3-3-73). Clinical skin irritation study data summary sheet on Myristic Acid in bar soap.*
264.
HTR. (Feb. 28, 1979). Submission of unpublished data by CTFA. (3-3-28). The study of cumulative irritant properties of a series of test materials. A clinical study on 5.0 percent Myristic Acid in a cleanser lotion.*
265.
CTFA. (Aug. 8, 1972). Submission of unpublished data. (3-3-9). Skin irritation potential (human patch test) data summary sheet on Stearic Acid.*
266.
CTFA. (Nov. 11, 1980). Submission of unpublished data (3-3-87). Clinical irritation and photosensitization study: Data summary sheet on Stearic Acid in face cream.*
267.
CTFA. (July 2, 1973). Submission of unpublished data. (3-3-88). Clinical controlled use study: Data summary sheet on Stearic Acid in face cream.*
268.
LEO WINTER ASSOCIATES. (July 28, 1980). Submission of unpublished data by CTFA. (3-3-94). Final report on prophetic patch and in-use testing on a shave foam containing 8 percent Stearic Acid.*
269.
HTR. (July 12, 1978). Submission of unpublished data by CTFA. (3-3-11). Repeated insult patch test of ten test samples. A clinical study on black paste mascara 10229-8 containing 7.7 percent Stearic Acid.*
270.
UNIVERSITY OF California, LOS ANGELES (UCLA). (Oct. 17, 1983). Submission of unpublished data by CTFA. (3-3-42). Twenty-one day cumulative irritation potential of two moisturizers containing 2.6 percent Stearic Acid.*
271.
CTFA. (Jan. 1984). Submission of unpublished data. (3-3-77). Clinical skin irritation study data summary sheet on 40 percent Oleic Acid in bar soaps.*
272.
Schwartz, L. and Peck, S.M. (1944). The patch test in contact dermatitis. Public Health Rep.59, 546–57.
273.
CTFA. (Dec. 30, 1974). Submission of unpublished data (3-3-68). Contact sensitizing potential of 6 percent Oleic Acid in humans.*
274.
HTR. (Aug. 19, 1983). Submission of unpublished data by CTFA. (3-3-98). Repeated insult patch test on a purple wax formulation containing 5 percent Oleic Acid.*
275.
UCLA. (Oct. 19, 1984). Submission of unpublished data by CTFA. (3-3-108). Modified Draize-Shelanski-Jordan repeat insult patch test in humans of a mascara containing 3 percent Stearic Acid.*
276.
UCLA. (March 12, 1985). Submission of unpublished data by CTFA. (3-3-106). Modified Draize-Shelanski-Jordan repeat insult patch test in humans of a mascara containing 2 percent Stearic Acid.*
277.
Maibach, H.I. (Aug. 2, 1982). Submission of unpublished data by CTFA. (3-3-703). Modified Draize skin sensitization study on human subjects of mascara containing 2 percent Oleic Acid.*
278.
PRODUCT Investigators, INC. (April 30, 1980). Submission of unpublished data by CTFA. (3-3-63). Evaluation of potential hazards by dermal contact (intact and abraded skin) of 1.95 percent Lauric Acid in a liquid soap.*
279.
CTFA. (Dec. 16, 1977). Submission of unpublished data. (3-3-19). Allergic contact sensitization test on 10.0 percent Stearic Acid.*
280.
CTFA. (Oct. 1980). Submission of unpublished data. (3-3-95). Clinical skin irritation and sensitization study on 10 percent Stearic Acid in a mascara composite.*
281.
HTR. (June 22, 1977). Submission of unpublished data by CTFA. (3-3-14). Repeated insult patch test of ten test samples. A clinical study on black paste mascara 10229-8 containing 7.7 percent Stearic Acid.*
282.
UCLA. (March 12, 1985). Submission of unpublished data by CTFA. (3-3-41). Modified Draize-Shelanski-Jordan repeat insult patch test in humans of a mascara containing 5 percent Stearic Acid.*
283.
CTFA. (Aug. 1, 1980). Submission of unpublished data. (3-3-20). Allergic contact sensitization test on 4.0 percent Stearic Acid.*
284.
FOOD AND DRUG RESEARCH Laboratories, INC. (FDRL). (Oct. 8>, 1980). Submission of unpublished data by CTFA. (3-3-112). Clinical safety evaluation of hand lotion containing 2.8 percent Stearic Acid. Repeat insult patch test.*
285.
TKL Research, INC. (May 24, 1983). Submission of unpublished data by CTFA. (3-3-119). Repeated insult patch test in humans on skin lotion containing 2.8 percent Stearic Acid.*
286.
RESEARCH TESTING LABORATORIES. (Dec. 12, 1978). Submission of unpublished data by CTFA. (3-3-12). Patch and usage study 620.0978: 2.66 percent Stearic Acid.*
287.
UCLA. (May 20, 1983). Submission of unpublished data by CTFA. (3-3-43). Modified Draize-Shelanski-Jordan patch test in humans of a moisturizer containing 2.6 percent Stearic Acid.*
288.
UCLA. (Aug. 10, 1983). Submission of unpublished data by CTFA. (3-3-44). Modified Draize-Shelanski-Jordan patch test in humans of a moisturizer containing 2.6 percent Stearic Acid.*
289.
UCLA. (March 16, 1984). Submission of unpublished data by CTFA. (3-3-45). Modified Draize-Shelanski-Jordan repeat insult patch test in humans of a sun lotion containing 2.6 percent Stearic Acid.*
290.
UCLA. (March 16, 1984). Submission of unpublished data by CTFA. (3-3-47). Modified Draize-Shelanski-Jordan repeat insult patch test in humans of a sun lotion containing 2.6 percent Stearic Acid.*
291.
UCLA. (March 16, 1984). Submission of unpublished data by CTFA. (3-3-48). Modified Draize-Shelanski-Jordan repeat insult patch test in humans of a sun block cream containing 2.6 percent Stearic Acid.*
292.
CTFA. (March 1978). Submission of unpublished data. (3-3-81). Clinical skin sensitization testing: data summary sheet on Stearic Acid in hand lotion.*
293.
CTFA. (Submission date, Oct. 23, 1985). Submission of unpublished data. (3-3-56). Modified Draize-Shelanski repeat insult patch test data summary sheet on Stearic Acid in suntan lotion.*
294.
IVY RESEARCH Laboratories, INC. (July 15, 1983). Submission of unpublished data by CTFA. (3-3-64). The appraisal of the contact-sensitizing potential of four (4) materials by means of the maximization study. A clinical study on a bar soap containing 23 percent Stearic Acid.*
295.
CTFA. (Dec. 9, 1983). Submission of unpublished data. (3-3-18). Allergic sensitization test on 25.0 percent Stearic Acid.*
296.
Shelanski, H.A. and Shelanski, M.V. (1953). A new technique of human patch tests. Proc. Joint Conf. Cosmet. Sci. Toilet Goods Assoc.19, 47–9.
297.
UCLA. (March 16, 1984). Submission of unpublished data by CTFA. (3-3-46). Modified Draize-Shelanski-Jordan repeat insult patch test in humans of a sun lotion containing 26 percent Stearic Acid.*
298.
CTFA. (March 25, 1983). Submission of unpublished data. 13-3-52), Evaluation of photosensitivity potential of topical products data summary sheet on Oleic Acid in blusher.*
299.
CTFA. (March 10, 1978). Submission of unpublished data. (3-3-59). Evaluation of photosensitivity potential of topical products data summary sheet on Oleic Acid in liquid makeup.*
300.
FEDERAL REGISTER. (Aug. 25, 1978). Sunscreen drug products for over-the-counter human drugs, pp. 28306–69.
301.
FDRL. (Dec. 2, 1981). Submission of unpublished data by CTFA. (3-3-114). Clinical safety evaluation of lotion containing 2.8 percent Stearic Acid. Phototoxicity test.*
302.
TKL Research, INC. (May 24, 1983). Submission of unpublished data by CTFA. (3-3-65). Phototoxicity test in humans on soap bar containing 23 percent Stearic Acid.*
303.
FDRL. (Dec. 2, 1981). Submission of unpublished data by CTFA. (3-3-117). Clinical safety evaluation of lotion containing 2.8 percent Stearic Acid. Photoallergy test.*
304.
FDRL. (Dec. 2, 1981). Submission of unpublished data by CTFA. (3-3-122). Clinical safety evaluation of skin lotion containing 2.8 percent Stearic Acid. Photoallergy test.*
305.
CTFA. (May 21, 1979). Submission of unpublished data. (3-3-58). Evaluation of photosensitivity potential of topical products data summary sheet on Stearic Acid in suntan lotion.*
306.
CTFA. (Aug. 1, 1979). Submission of unpublished data. (3-3-53). Evaluation of photosensitivity potential of topical products data summary sheet on Oleic Acid in moisturizing lotion.*
307.
CTFA. (April 2, 1980). Submission of unpublished data. (3-3-54). Evaluation of photosensitivity potential of topical products data summary sheet on Stearic Acid in facial lotion.*
308.
CTFA. (Oct. 22, 1982). Submission of unpublished data. (3-3-57). Evaluation of photosensitivity potential of topical products data summary sheet on Stearic Acid in suntan lotion.*
309.
MED Check, INC. (June 11, 1982). Submission of unpublished data by CTFA. (3-3-104). Ocular evaluation of eye area cosmetics in humans. Mascara containing 2 percent Oleic Acid.*
310.
MED Check, INC. (May 1, 1985). Submission of unpublished data by CTFA. (3-3-100, 3-3-109). Ocular evaluation of eye area cosmetics in humans. Mascara formulations containing 2 percent and 3 percent Oleic Acid.*
311.
Kihl, B. and Olbe, L. (1981). Inhibition of pentagastrin-stimulated gastric acid secretion by graded intraduodenal administration of oleic acid in man. Scand. J. Castroenterol.16(1), 121–8.
312.
Kihl, B., Rokaeus, A., Rosell, S., and Olbe, L. (1981). Fat inhibition of gastric acid secretion in man and plasma concentrations of neurotensin-like immunoreactivity. Scand. J. Castroenterol.16(4), 513–26.
313.
Owyang, C., Green, L., and Rader, D. (1983). Colonic inhibition of pancreatic and biliary secretion. Gastroenterology84(3), 470–5.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
